What is Reditux (Rituximab)
Rituximab belongs to a group of cancer drugs known as monoclonal antibodies. Monoclonal antibodies are sometimes called targeted therapies because they work by ‘targeting’ specific proteins (receptors) on the surface of cells.
Rituximab is used to treat several types of CD20-positive NHL (NHL where CD20 is found on the surface of the cancer cells). It may also be used to treat CLL. It’s often given in combination with chemotherapy, but it may be given on its own. Your doctor or specialist nurse can tell you whether rituximab is suitable for your situation.Rituximab may also be used to treat other, non-cancerous conditions.
100 mg (1 vial)
500 mg (1 Vial)
Storage and handling:
Store at 2°- 8° C
How do we source the Drug?
SSPWL will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Company that Manufactures/ Markets:
M/s Dr Reddy’s
Call: +91 07738100125 / +91 07738151650 or